These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 11200072

  • 21. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
    Wattrang E.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):218-28. PubMed ID: 19447503
    [Abstract] [Full Text] [Related]

  • 22. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.
    Exp Hematol; 2008 Jan 15; 36(1):69-77. PubMed ID: 17959301
    [Abstract] [Full Text] [Related]

  • 23. Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells.
    Sivori S, Carlomagno S, Moretta L, Moretta A.
    Eur J Immunol; 2006 Apr 15; 36(4):961-7. PubMed ID: 16525994
    [Abstract] [Full Text] [Related]

  • 24. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
    Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C.
    Exp Hematol; 2000 May 15; 28(5):558-68. PubMed ID: 10812246
    [Abstract] [Full Text] [Related]

  • 25. CpG oligodeoxynucleotides stimulate immune cell proliferation but not specific antibody production in rainbow trout (Oncorhynchus mykiss).
    Carrington AC, Collet B, Holland JW, Secombes CJ.
    Vet Immunol Immunopathol; 2004 Oct 15; 101(3-4):211-22. PubMed ID: 15350751
    [Abstract] [Full Text] [Related]

  • 26. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M.
    Eur J Immunol; 2007 Jul 15; 37(7):1785-95. PubMed ID: 17557373
    [Abstract] [Full Text] [Related]

  • 27. Early activation markers of human peripheral dendritic cells.
    Hellman P, Eriksson H.
    Hum Immunol; 2007 May 15; 68(5):324-33. PubMed ID: 17462499
    [Abstract] [Full Text] [Related]

  • 28. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P.
    Cancer Res; 2003 Jun 01; 63(11):2836-43. PubMed ID: 12782589
    [Abstract] [Full Text] [Related]

  • 29. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide.
    Gürsel M, Verthelyi D, Gürsel I, Ishii KJ, Klinman DM.
    J Leukoc Biol; 2002 May 01; 71(5):813-20. PubMed ID: 11994506
    [Abstract] [Full Text] [Related]

  • 30. B-cell activation in patients with irritable bowel syndrome (IBS).
    Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, Sjövall H, Simrén M.
    Neurogastroenterol Motil; 2009 Jun 01; 21(6):644-50, e27. PubMed ID: 19222763
    [Abstract] [Full Text] [Related]

  • 31. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
    Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.
    J Leukoc Biol; 2008 Feb 01; 83(2):434-7. PubMed ID: 17998303
    [Abstract] [Full Text] [Related]

  • 32. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W, Chan AS, Dawson AJ, Liang X, Blazar BR, Miller JS.
    Biol Blood Marrow Transplant; 2005 Jan 01; 11(1):23-34. PubMed ID: 15625541
    [Abstract] [Full Text] [Related]

  • 33. Synergism between cytosine-guanine oligodeoxynucleotides and monoclonal antibody in the treatment of lymphoma.
    Warren TL, Weiner GJ.
    Semin Oncol; 2002 Feb 01; 29(1 Suppl 2):93-7. PubMed ID: 11842395
    [Abstract] [Full Text] [Related]

  • 34. Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching.
    Herbáth M, Papp K, Erdei A, Prechl J.
    J Immunol Res; 2015 Feb 01; 2015():340468. PubMed ID: 26380319
    [Abstract] [Full Text] [Related]

  • 35. Synergism between cytosine-guanine oligodeoxynucleotides and monoclonal antibody in the treatment of lymphoma.
    Warren TL, Weiner GJ.
    Semin Oncol; 2002 Feb 01; 29(1S2):93-97. PubMed ID: 28140098
    [Abstract] [Full Text] [Related]

  • 36. B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21.
    Hagn M, Blackwell SE, Beyer T, Ebel V, Fabricius D, Lindner S, Stilgenbauer S, Simmet T, Tam C, Neeson P, Trapani JA, Schrezenmeier H, Weiner GJ, Jahrsdörfer B.
    Int Immunol; 2014 Jul 01; 26(7):383-95. PubMed ID: 24497611
    [Abstract] [Full Text] [Related]

  • 37. Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity.
    Zorro S, Arias M, Riaño F, Paris S, Ramírez LA, Uribe O, García LF, Vásquez G.
    Lupus; 2009 Jul 01; 18(8):718-26. PubMed ID: 19502268
    [Abstract] [Full Text] [Related]

  • 38. Enhancing radiosensitivity of human pulmonary adenocarcinoma cell line A549 by CpG ODN1826.
    Li R, Song Y, Chen W.
    Cancer Biother Radiopharm; 2011 Feb 01; 26(1):69-76. PubMed ID: 21355778
    [Abstract] [Full Text] [Related]

  • 39. Activation of antigen-presenting cells by immunostimulatory plant DNA: a natural resource for potential adjuvant.
    Wang Y, Wang W, Li N, Yu Y, Cao X.
    Vaccine; 2002 Jun 21; 20(21-22):2764-71. PubMed ID: 12034103
    [Abstract] [Full Text] [Related]

  • 40. CpG oligodeoxynucleotides discriminately enhance binding capacity of human naïve B cells to Hepatitis B virus epitopes.
    Bai JY, Yang YT, Zhu R, Wang YQ, Tian Y, Li XH, Wang RQ.
    Can J Microbiol; 2012 Jun 21; 58(6):752-9. PubMed ID: 22625205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.